LoRusso PM - Search Results

1

Phase I and pharmacokinetic study of lapatinib and docetaxel in patients with advanced cancer.

LoRusso PM, Jones SF, Koch KM, Arya N, Fleming RA, Loftiss J, Pandite L, Gadgeel S, Weber BL, Burris HA 3rd. LoRusso PM, et al. J Clin Oncol. 2008 Jun 20;26(18):3051-6. doi: 10.1200/JCO.2007.14.9633. J Clin Oncol. 2008. PMID: 18565892 Clinical Trial.

2

Low-dose continuous infusion 5-fluorouracil and cisplatin: phase II evaluation in advanced colorectal carcinoma.

LoRusso P, Pazdur R, Redman BG, Kinzie J, Vaitkevicius V. LoRusso P, et al. Am J Clin Oncol. 1989 Dec;12(6):486-90. doi: 10.1097/00000421-198912000-00005. Am J Clin Oncol. 1989. PMID: 2686394 Review.

3

Phase I study of monoclonal antibody-ricin A chain immunoconjugate Xomazyme-791 in patients with metastatic colon cancer.

LoRusso PM, Lomen PL, Redman BG, Poplin E, Bander JJ, Valdivieso M. LoRusso PM, et al. Am J Clin Oncol. 1995 Aug;18(4):307-12. doi: 10.1097/00000421-199508000-00008. Am J Clin Oncol. 1995. PMID: 7625372 Clinical Trial.

4

Phase II study of pyrazoloacridine in patients with advanced colorectal carcinoma.

Zalupski MM, Philip PA, LoRusso P, Shields AF. Zalupski MM, et al. Cancer Chemother Pharmacol. 1997;40(3):225-7. doi: 10.1007/s002800050650. Cancer Chemother Pharmacol. 1997. PMID: 9219505 Clinical Trial.

5

Phase II evaluation of cisplatin and WR2721 for refractory metastatic breast cancer.

Ramnath N, LoRusso P, Simon M, Martino S. Ramnath N, et al. Am J Clin Oncol. 1997 Aug;20(4):368-72. doi: 10.1097/00000421-199708000-00009. Am J Clin Oncol. 1997. PMID: 9256891 Clinical Trial.

6

Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma.

Zalupski MM, Shields AF, Philip PA, Kraut M, LoRusso P, Heilbrun LK, Vaitkevicius V. Zalupski MM, et al. Invest New Drugs. 1998;16(1):93-6. doi: 10.1023/a:1006087114621. Invest New Drugs. 1998. PMID: 9740550 Clinical Trial.

7

Pharmacokinetic studies in mice of two new thioxanthenones (183577 and 232759) that showed preferential solid tumor activity.

Foster BJ, Wiegand RA, Pugh S, LoRusso PM, Rake J, Corbett TH. Foster BJ, et al. Among authors: lorusso pm. Clin Cancer Res. 1997 Nov;3(11):2047-53. Clin Cancer Res. 1997. PMID: 9815596

8

Phase I clinical trial of pyrazoloacridine NSC366140 (PD115934).

LoRusso P, Foster BJ, Poplin E, McCormick J, Kraut M, Flaherty L, Heilbrun LK, Valdivieso M, Baker L. LoRusso P, et al. Clin Cancer Res. 1995 Dec;1(12):1487-93. Clin Cancer Res. 1995. PMID: 9815948 Clinical Trial.

9

Phase II study of CI-958 in colorectal cancer.

Shields AF, Philip PA, LoRusso PM, Ferris AM, Zalupski MM. Shields AF, et al. Among authors: lorusso pm. Cancer Chemother Pharmacol. 1999;43(2):162-4. doi: 10.1007/s002800050878. Cancer Chemother Pharmacol. 1999. PMID: 9923823 Clinical Trial.

10

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer.

Blum JL, Jones SE, Buzdar AU, LoRusso PM, Kuter I, Vogel C, Osterwalder B, Burger HU, Brown CS, Griffin T. Blum JL, et al. Among authors: lorusso pm. J Clin Oncol. 1999 Feb;17(2):485-93. doi: 10.1200/JCO.1999.17.2.485. J Clin Oncol. 1999. PMID: 10080589 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

345 results

Search Page

Filters